Pages that link to "Q69508432"
Jump to navigation
Jump to search
The following pages link to T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads (Q69508432):
Displaying 12 items.
- Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation (Q34279672) (← links)
- Hematopoietic cellular therapy: implications for the flow cytometry laboratory (Q34718365) (← links)
- Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning? (Q35022487) (← links)
- Novel approaches in allogeneic stem cell transplantation (Q36562204) (← links)
- T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells (Q38514497) (← links)
- Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future. (Q38742867) (← links)
- Newly established human pancreatic carcinoma cell lines and their lectin binding properties. (Q42810312) (← links)
- Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease. (Q52763837) (← links)
- Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies (Q61651680) (← links)
- The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation (Q78179095) (← links)
- Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation (Q90029164) (← links)
- 'Off-the-shelf' allogeneic CAR T cells: development and challenges (Q92407428) (← links)